SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001144204-17-033829
Filing Date
2017-06-23
Accepted
2017-06-23 16:06:21
Documents
24
Period of Report
2017-06-23

Document Format Files

Seq Description Document Type Size
1 6-K/A v469163_6ka.htm 6-K/A 16871
  Complete submission text file 0001144204-17-033829.txt   805749

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE glmd-20160630.xml EX-101.INS 72302
3 XBRL SCHEMA FILE glmd-20160630.xsd EX-101.SCH 11838
4 XBRL CALCULATION FILE glmd-20160630_cal.xml EX-101.CAL 22891
5 XBRL DEFINITION FILE glmd-20160630_def.xml EX-101.DEF 87515
6 XBRL LABEL FILE glmd-20160630_lab.xml EX-101.LAB 115316
7 XBRL PRESENTATION FILE glmd-20160630_pre.xml EX-101.PRE 96612
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-36345 | Film No.: 17927636
SIC: 2834 Pharmaceutical Preparations